SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in MIRM — Mirum Pharmaceuticals, Inc.
CIK 1232395
NEW YORK, NY
Position in MIRM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,481,948
+$368,425 QoQ
Shares Held
80,991
-10.1% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 63.41074934251954.ToString("F0")%
Shared 0.ToString("F0")%
None 36.58925065748046.ToString("F0")%
Common Shares in MIRM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $95,938,613 across 21 Biotechnology names. MIRM ranks #3 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
959,207 | $30,857,689 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
15,963 | $8,356,151 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
This page
|
80,991 | $7,481,948 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,358 | $7,304,501 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
108,413 | $6,797,495 | |
| 6 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
163,633 | $5,943,150 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
47,931 | $5,051,927 | |
| 8 | ZYME |
Zymeworks Inc.
|
163,649 | $4,097,770 |
All Filings in MIRM
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,481,948 | 80,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,113,523 | 90,056 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,602,005 | 90,056 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,916,714 | 135,915 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,122,970 | 135,915 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,652,545 | 136,700 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,383,833 | 138,047 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,538,553 | 220,490 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,089,963 | 162,817 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,920,885 | 98,946 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,816,156 | 152,410 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,060,513 | 234,268 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,837,147 | 201,380 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,926,910 | 201,380 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,362,377 | 160,037 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,198,971 | 164,387 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,785,568 | 171,915 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,565,528 | 286,240 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||